Comparison between Jiwanram Sheoduttrai IPO and Saroja Pharma IPO.
IPO Details
Jiwanram Sheoduttrai IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Jiwanram Sheoduttrai IPO is up to ₹16.22 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Jiwanram Sheoduttrai IPO is ₹23.00 per share and of Saroja Pharma IPO is ₹84.00 per share.
IPO Timetable
Jiwanram Sheoduttrai IPO opens on Sep 08, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Jiwanram Sheoduttrai IPO and Saroja Pharma IPO is Sep 12, 2023, and Sep 05, 2023, respectively.
| | Jiwanram Sheoduttrai IPO | Saroja Pharma IPO |
|---|
| Issue Open | Sep 08, 2023 | Aug 31, 2023 |
| Issue Close | Sep 12, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 15, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 18, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 20, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 18, 2023 | Sep 13, 2023 |
Financials & KPIs
Jiwanram Sheoduttrai IPO P/E ratio is 9.91, as compared to Saroja Pharma IPO P/E ratio of 23.25.
Shares Offered
In the Jiwanram Sheoduttrai IPO Retail Individual Investors (RII) are offered 35,28,000 shares while in Saroja Pharma IPO retail investors are offered 35,28,000 shares. Qualified Institutional Buyers (QIB) are offered in Jiwanram Sheoduttrai IPO and in Saroja Pharma IPO.
| | Jiwanram Sheoduttrai IPO | Saroja Pharma IPO |
|---|
| Market Maker Reservation | 3,72,000 shares | 54,400 shares |
| NII | 35,22,000 shares | 5,15,200 shares |
| RII | 35,28,000 shares | 5,15,200 shares |
| Total | 70,50,000 shares | 10,30,400 shares |
Bids Received (Subscription)
Jiwanram Sheoduttrai IPO subscribed 110.65x in total, whereas Saroja Pharma IPO subscribed 8.86x.
